Status:
COMPLETED
Laparoscopic Surgical Treatment of Aorto-iliac Occlusive Disease
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
Sykehuset Ostfold
Sorlandet Hospital HF
Conditions:
Aorto Iliac Occlusive Disease
Eligibility:
All Genders
Brief Summary
Patients with aorto-iliac occlusive disease (TASC, type D) operated with a totally laparoscopic aortobifemoral bypass operation and open aortobifemoral bypass operation will be followed up and the res...
Detailed Description
Patients with aorto-iliac occlusive disease (TASC, type D) operated with a totally laparoscopic aortobifemoral bypass operation and open aortobifemoral bypass operation will be followed up and the res...
Eligibility Criteria
Inclusion
- All patients with a TASC D lesion in the aorto-iliac segment not amenable to or previously unsuccessfully treated by endovascular approach.
- Exclusion Criteria:
- Unsuitable for surgery due to general health status
Exclusion
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01259908
Start Date
September 1 2010
End Date
May 1 2023
Last Update
June 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway, 0424